Ranibizumab vs Aflibercept for Macular Oedema in Branch RVO
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Twelve-Month Outcomes of Ranibizumab Versus Aflibercept for Macular Oedema in Branch Retinal Vein Occlusion: Data From the FRB! Registry
Br J Ophthalmol 2021 Mar 12;[EPub Ahead of Print], AR Hunt, V Nguyen, CP Creuzot-Garcher, S Alforja, PH Gabrielle, J Zarranz-Ventura, M Guillemin, S Fraser-Bell, RP Casaroli Marano, J Arnold, IL McAllister, L O'Toole, MC Gillies, D Barthelmes, H MehtaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.